Global Tissue Engineering Market to Surpass US$ 22,908.1 Million by 2030 - Coherent Market Insights

SEATTLE, Aug. 9, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global tissue engineering market is estimated to be valued at US$ 9,436.0 million in 2022 and is expected to exhibit a CAGR of 11.7% during the forecast period (2022-2030).

Key Trends and Analysis of the Global Tissue Engineering Market:

Major players operating in the market are focusing on adopting growth strategies such as new product launch and approvals which is expected to drive the market growth over the forecast period. For instance, in June 2021, Mallinckrodt plc, a global biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen – dsat) for the treatment of adults with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated (deep partial-thickness burns).

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2217 

Key Market Takeaways:

The global tissue engineering market is expected to exhibit a CAGR of 11.7% during the forecast period due to technological advancements in 3D bio-printing, and potential pipeline products as 3D bioprinting is a rapidly developing industry used for a variety of biomedical applications.

Among material type, synthetic segment is expected to hold a dominant position over the forecast period, owing to its properties such as biocompatibility, non-toxicity, biodegradability, good cell recognition properties, and easy functionalization is expected to drive the growth of the segment.

On the basis of application, orthopedic segment is expected to hold a dominant position over the forecast period, owing to development of tissue engineered products for orthopedic and musculoskeletal applications, increased commercialization of tissue engineered products for bone and cartilage repair, wide availability of products, and increase in the incidence of musculoskeletal disorders with increased awareness of tissue engineered.

Key players operating in the global tissue engineering market include Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/2217

Detailed Segmentation:

Global Tissue Engineering Market, By Material Type:

• Synthetic
• Biological
• Others

Global Tissue Engineering Market, By Application:

• Dermal
• Orthopedic
• Dental
• Neurology
• Others

Global Tissue Engineering Market, By Region:

• North America
• By Country:
• U.S.
• Canada
• Europe 
• By Country:
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country:
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• By Country:
• GCC Countries
• Israel
• South Africa
• Rest of Middle East & Africa

Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/2217

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com 
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg